(Q33848339)

29 July 2017

1 reference

title

Some views on proteomics in diabetes (English)

1 reference

29 July 2017

Annunziata Lapolla

1

1 reference

PubMed ID

21410413

29 July 2017

Simona Porcu

series ordinal

2

1 reference

PubMed ID

21410413

29 July 2017

Pietro Traldi

series ordinal

3

1 reference

29 July 2017

17 March 2011

1 reference

Clinical Chemistry and Laboratory Medicine

29 July 2017

1 reference

29 July 2017

49

1 reference

29 July 2017

6

1 reference

29 July 2017

943-957

1 reference

Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments

29 July 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complicat

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

The in vitro glycation of lysozyme and the influence of buffer concentration investigated by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

A polymorphism within the fructosamine-3-kinase gene is associated with HbA1c Levels and the onset of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

The fructosamine 3-kinase knockout mouse: a tool for testing the glycation hypothesis of intracellular protein damage in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Enzymatic deglycation--a new paradigm or an epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

A mammalian protein homologous to fructosamine-3-kinase is a ketosamine-3-kinase acting on psicosamines and ribulosamines but not on fructosamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Impaired agglutination of IgM resulting from non-enzymatic glycation in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and molecular modeling in the study of nonenzymatic glycation of IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Haemoglobin A1c: Analysis and Standardisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Approved IFCC reference method for the measurement of HbA1c in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Direct evaluation of glycated and glyco-oxidized globins by matrix-assisted laser desorption/ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

New insights into the regulation of HDL metabolism and reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Regulation of reverse cholesterol transport and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Reverse cholesterol transport in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Bioinformatics in mass spectrometry data analysis for proteomics studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Do collisions inside the collision cell play a relevant role in CID-LIFT experiments?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

InsPecT: identification of posttranslationally modified peptides from tandem mass spectra

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Advanced glycation end-products: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Relation between serum 3-deoxyglucosone and development of diabetic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Glycation free adduct accumulation in renal disease: the new AGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Urinary proteomics in diabetes and CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

Proteomic analysis for the assessment of diabetic renal damage in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.151

21 January 2018

Identifiers

DOI

10.1515/CCLM.2011.151

1 reference

29 July 2017

1 reference

PubMed ID

21410413